MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ionic Fusion Launches New Corporation

Originally Published MDDI March 2005 Outsourcing News  

Originally Published MDDI March 2005

Outsourcing News

Nanosurface technology from Nexxion could be applied to a variety of already-assembled implants and surgical tools.

Ionic Fusion Corp. (Longmont, CO) chose the MD&M West trade show in January to introduce Nexxion Corp. (Longmont) as its medical subsidiary. Ionic Fusion markets the Ionic Plasma Deposition (IPD) process, a vacuum-impregnation nanotech technique that can be used for medical applications such as implants, surgical tools, and drug-eluting nanostructures. The proprietary process can also impregnate silver oxide into substrate material at room temperature.

The subsidiary company was formed to develop, manufacture, and distribute service equipment that is part of the IPD technology. “Our IPD process can be applied to already assembled medical devices, with a precision, penetration, and uniformity not possible before,” says Dave Tobler, managing director of Nexxion Corp.

Copyright ©2005 Medical Device & Diagnostic Industry

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.